Imaging of facial nerve schwannomas: diagnostic pearls and potential pitfalls

Schwannomas are uncommon in the facial nerve and account for less than 1% of tumors of temporal bone. They can involve one or more than one segment of the facial nerve. The clinical presentations and the imaging appearances of facial nerve schwannomas are influenced by the topographical anatomy of the facial nerve and vary according to the segment(s) they involve. This pictorial essay illustrates the imaging features of facial nerve schwannomas according to their various anatomical locations and also reviews the pertinent differential diagnoses and potential diagnostic pitfalls.Facial nerve schwannomas (FNSs) are rare slow-growing tumors, accounting for less than 1% of all temporal bone tumors. They are typically solitary, unilateral, and sporadic in nature. FNSs may be bilateral as part of neurofibromatosis-2 spectrum (1, 2). Rarely, multiple schwannomas may involve peripheral branches of the facial nerve (FN) (3). The age of presentation varies from 5 to 84 years. No gender or side predilection is seen (4, 5).Histologically, FNSs are neuroectodermal in origin. They are encapsulated, benign tumors arising from the Schwann cells. They may show intratumoral cystic change and hemorrhage (3, 4, 5). Malignant schwannoma of the FN is extremely rare (6). FNSs commonly present with peripheral facial neuropathy and/or various otologic symptoms including sensorineural and conducting hearing loss (2–5). Facial paralysis is often seen at a later stage or may not be seen at all. The reasons for this are thought to be neuronal tolerance induced by the extremely slow growth of the tumor, abundant tumor vascularity, and commonly associated dehiscence of adjacent bone (7). Occasionally, FNSs may present as an intraparotid mass or as an intracranial lesion (2–5).The clinical presentations and the imaging appearances of FNSs are influenced by the topographical imaging anatomy of the FN and vary according to the segment(s) they involve (8). Here, we briefly describe the anatomy of the FN, followed by general imaging features of FNSs on computed tomography (CT) and magnetic resonance imaging (MRI), and appropriate imaging protocols. Tumor involving each segment is reviewed in relation to its characteristic clinical presentations emphasizing diagnostic pearls and potential pitfalls. The imaging examples of FNSs illustrated in this pictorial review are all histopathologically proven cases.     

Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions

PURPOSE

The aim of this study was to determine the incidence of invasive breast carcinoma in patients with preoperative diagnosis of ductal carcinoma in situ (DCIS) by stereotactic vacuum-assisted biopsy (SVAB) performed for microcalcification-only lesions, and to identify the predictive factors of invasion.

METHODS

From 2000 to 2010, the records of 353 DCIS patients presenting with microcalcification-only lesions who underwent SVAB were retrospectively reviewed. The mammographic size of microcalcification cluster, presence of microinvasion within the cores, the total number of calcium specks, and the number of calcium specks within the retrieved core biopsy specimen were recorded. Patients were grouped as those with or without invasion in the final pathologic report, and variables were compared between the two groups.

RESULTS

The median age was 58 years (range, 34–88 years). At histopathologic examination of the surgical specimen, 63 of 353 patients (17.8%) were found to have an invasive component, although SVAB cores had only shown DCIS preoperatively. The rate of underestimation was significantly higher in patients with microcalcification covering an area of 40 mm or more, in the presence of microinvasion at biopsy, and in cases where less than 40% of the calcium specks were removed from the lesion.

CONCLUSION

Invasion might be underestimated in DCIS cases diagnosed with SVAB performed for microcalcification-only lesions, especially when the mammographic size of calcification is equal to or more than 40 mm or if microinvasion is found within the biopsy specimen and less than 40% of the calcifications are removed. At least 40% of microcalcification specks should be removed from the lesion to decrease the rate of underestimation with SVAB.Because of the widespread use of breast screening mammography, the number of women diagnosed with ductal carcinoma in situ (DCIS) has increased dramatically in recent years. DCIS is a noninvasive form of breast cancer, accounting for up to 30% of breast cancers in screening populations and approximately 5% of breast carcinomas in symptomatic patients (1–3). DCIS has a variety of mammographic presentations, but the most common mammographic feature is microcalcification (4). Indeed 80%–90% of DCIS lesions present with microcalcifications only, without any accompanying mass lesions (4). Other findings such as masses, nodular abnormalities, dilated retroareolar ducts, architectural distortions, and developing densities have also been reported (5).Ultrasound-guided biopsy is often the method of choice for sonographically visible breast lesions as it provides easy access for biopsy. However, in cases when the abnormality seen on mammography is not visible on ultrasonography, stereotactic biopsy is the recommended sampling method. For microcalcification-only lesions with no accompanying mass, ultrasonography often fails to identify the site of the lesion; hence, stereotactic biopsy is used more frequently.In most breast units, stereotactic 14-gauge automated core biopsy has been replaced by stereotactic vacuum-assisted biopsy (SVAB) using 8- to 11-gauge needles (6). Large core SVAB allows larger samples to be obtained in a shorter period of time compared with samples obtained using automated core biopsy devices (7). Moreover, this technique has the advantage of a single insertion in the area of interest compared with automated core biopsy devices, which require repeated insertions. Several published articles have shown that SVAB decreased the rate of cancer underestimation and the rate of failure to retrieve breast microcalcifications (8).The management of noninvasive and invasive breast cancers is different and therefore, an accurate preoperative diagnosis is crucial for adequate surgical planning. Underestimation of DCIS lesions occurs when an invasive component is found after surgery, which had been missed at the initial preoperative sampling. The underestimation rate of stereotactic 14-gauge automated core biopsy in DCIS was reported as 16%–35% (9–11), while that of SVAB was 5%–29% (6, 9, 11–13).The purpose of this study was to determine the rate, causes, and predictive factors of underestimation of invasive carcinoma in patients diagnosed with DCIS following SVAB of microcalcification-only lesions.     

An innovative modification of the retrograde approach to angioplasty and recanalization of the superficial femoral artery

Endovascular therapy has been performed for chronic limb ischemia for nearly 50 years. Superficial femoral artery occlusions can be managed by the retrograde contralateral (“crossover”), antegrade ipsilateral, or retrograde popliteal (“facedown”) approaches. The retrograde approach was initially fraught with limitations and served as a backup option. Refinements to this technique have made it an enticing option and possibly the first choice in selected patients. We herein describe an innovative modification of this method.Endovascular therapy has been performed for chronic limb ischemia since 1964, with intraluminal and subintimal angioplasty of the superficial femoral artery (SFA) gaining popularity in the last decade (1). SFA occlusions can be managed by retrograde contralateral or antegrade ipsilateral approaches (2, 3); when these approaches fail, some practitioners resort to using a re-entry device (4, 5). The retrograde popliteal approach was initially fraught with limitations and served as a backup option (1, 4, 6). However, refinements to this technique have made this an enticing option (2–7), and it has been advocated as a first-line treatment in select patients (3). We herein describe another modification of this method.     

CT mapping of the vertebral level of right adrenal vein

PURPOSE

We aimed to evaluate the accuracy of multidetector computed tomography (MDCT) venous mapping for the localization of the right adrenal veins (RAV) in patients suffering from primary aldosteronism.

METHODS

MDCT scans of 75 patients with primary aldosteronism between March 2008 and November 2011 were evaluated by two readers (a junior [R1] and a senior [R2] radiologist) according to the following criteria: quality of RAV depiction (scale, 1–5), localization of the RAV confluence with regard to the inferior vena cava, and depiction of anatomical variants. Results were compared with RAV venograms obtained during adrenal vein sampling and corroborated by laboratory testing of cortisol in selective RAV blood samples. Kappa statistics were calculated for interobserver agreement and for concordance of MDCT mapping with the gold standard.

RESULTS

Successful RAV sampling was achieved in 69 of 75 patients (92%). Using MDCT mapping, adrenal veins could be visualized in 78% (R1, 54/69) and 77% (R2, 53/69) of patients. MDCT mapping led to correct identification of RAV in 70% (R1, 48/69) and 88% (R2, 61/69) of patients. Venograms revealed five cases of anatomical variants, which were correctly identified in 60% (R1, R2). MDCT-based localizations were false or misleading in 16% (R1, 11/69) and 7% (R2, 5/69) of cases.

CONCLUSION

Preinterventional MDCT mapping may facilitate successful catheterization in adrenal vein sampling.Primary aldosteronism (PA) has lately been claimed to be one of the most common causes of secondary hypertension, with reports indicating a prevalence of more than 10% (1, 2), especially in patients with resistant hypertension (3). While PA is more common than previously thought, the majority of cases is not accompanied by the full clinical picture of Conn’s syndrome (triad of hypertension, hypokalemia, and metabolic alkalosis), and many patients are in fact normokalemic. In addition to its role in causing hypertension, PA may also be an independent cardiovascular risk factor, as demonstrated by higher cardiovascular and renal morbidity in patients suffering from PA in comparison to matched controls with essential hypertension (2, 4, 5). PA is caused either by an aldosterone-producing adenoma (65%–70% of cases) or bilateral adrenal hyperplasia (30%–35% of cases), whereas unilateral adrenal hyperplasia, aldosterone-producing carcinomas, or an ectopic secretion of aldosterone are rare (6). Differentiation of the underlying condition is crucial for the treatment of patients with PA: while unilateral disease can be cured by laparoscopic adrenalectomy, cases of bilateral aldosterone secretion will be medically treated with mineralocorticoid receptor antagonists.The 2008 Endocrine Society Clinical Practice Guidelines recommend computed tomography (CT) of the adrenal region in all patients with biochemically confirmed PA, to rule out malignancy (2). The primary indication does not involve the subtype differentiation of PA, because multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) have both been proven to be scarcely sensitive and specific in the detection of aldosterone-producing adenomas (7). Hence, adrenal vein sampling (AVS) continues to represent the gold standard in the subtype differentiation of PA. However, AVS is a technically demanding interventional procedure even in experienced institutions. While the catheterization of the left adrenal vein is usually uncomplicated, sampling of the right adrenal vein (RAV) is often more challenging. Therefore, in the majority of cases successful bilateral AVS fails because of the missing catheterization on the right side (8–10). Published success rates for this procedure range from 42% up to 98% in experienced hands (11).Few authors have mentioned the possible advantage of reading CT-scans prior to AVS to identify the RAV (8, 12). To our knowledge, this is the first report on venous MDCT mapping for AVS. The purpose of this study was to evaluate the usefulness of newly introduced MDCT venous mapping for the localization of the RAV prior to selective catheterization in patients suffering from PA.     

Optimal reconstruction interval in dual source CT coronary angiography: a single-center experience in 285 patients

PURPOSE

We aimed to evaluate the visibility of coronary arteries and bypass-grafts in patients who underwent dual source computed tomography (DSCT) angiography without heart rate (HR) control and to determine optimal intervals for image reconstruction.

MATERIALS AND METHODS

A total of 285 consecutive cases who underwent coronary (n=255) and bypass-graft (n=30) DSCT angiography at our institution were identified retrospectively. Patients with atrial fibrillation were excluded. Ten datasets in 10% increments were reconstructed in all patients. On each dataset, the visibility of coronary arteries was evaluated using the 15-segment American Heart Association classification by two radiologists in consensus.

RESULTS

Mean HR was 76±16.3 bpm, (range, 46–127 bpm). All coronary segments could be visualized in 277 patients (97.19%). On a segment-basis, 4265 of 4275 (99.77%) coronary artery segments were visible. All segments of 56 bypass-grafts in 30 patients were visible (100%). Total mean segment visibility scores of all coronary arteries were highest at 70%, 40%, and 30% intervals for all HRs. The optimal reconstruction intervals to visualize the segments of all three coronary arteries in descending order were 70%, 60%, 80%, and 30% intervals in patients with a mean HR <70 bpm; 40%, 70%, and 30% intervals in patients with a mean HR 70–100 bpm; and 40%, 50%, and 30% in patients with a mean HR >100 bpm.

CONCLUSION

Without beta-blocker administration, DSCT coronary angiography offers excellent visibility of vascular segments using both end-systolic and mid-late diastolic reconstructions at HRs up to 100 bpm, and only end-systolic reconstructions at HRs over 100 bpm.Improvements in computed tomography (CT) scanning technology throughout the last decade have resulted in widespread acceptance of contrast-enhanced multidetector CT (MDCT) coronary angiography as a reliable modality for noninvasive evaluation of the coronary arteries (1). Having a high negative predictive value, MDCT coronary angiography is considered particularly beneficial in patients with low to intermediate pretest probability for coronary artery disease (CAD) by reliably excluding coronary artery stenosis and therefore, preventing unnecessary invasive angiography (2, 3).Small dimensions and continuous rapid motions of coronary arteries make their visualization by CT challenging. Thus, excellent spatial and temporal resolution is required for adequate imaging of coronary arteries. Initial reports using a 4-detector row MDCT were promising in selected patients with low heart rates (HRs) (4–6); however, image quality was not sufficient for assessment in up to 29% of the coronary segments. With the introduction of 16- and 64-row MDCT, major improvements of image quality were achieved, with adequate visualization of up to 97% of coronary segments (7–9). Since, image quality deteriorates with increasing HRs even with 64-slice MDCT scanners (10, 11), it has been common in clinical practice to use HR-modulating beta-blockers to achieve better diagnostic quality. In 2005, dual source CT (DSCT) system equipped with two sets of X-ray tubes and corresponding detectors mounted onto the gantry with an angular offset of 90° was introduced (12). Using half-scan reconstruction algorithms, this system provides high temporal resolution (83 milliseconds [ms]) that corresponds to a quarter gantry rotation time. Preliminary studies without use of beta-blocker premedication have shown that DSCT coronary angiography provides good image quality of coronary arteries even at a relatively high HR (13, 14). Subsequent studies with relatively small patient populations confirmed these findings with diagnostic image quality in 97.8% of coronary artery segments (15, 16).Achievement of good image quality with DSCT coronary angiography is highly dependent upon selecting the optimal reconstruction interval for evaluation. Previous publications indicate a relationship between optimal reconstruction window and HR with mid- to end-diastolic reconstructions providing better image quality at low HRs, whereas at faster HRs, end-systolic reconstructions will often provide the dataset with the least motion artifact (17–19). However, some of these prior studies were based on relatively small patient samples, and in some, the entire R-R interval was not evaluated. Detection of optimal reconstruction interval is also important for the purpose of radiation dose reduction. Since DSCT scanners are equipped with electrocardiogram (ECG)-based tube current modulation, the width and timing of the ECG pulsing window, during which the full tube current is given, can be manually selected by the operator with the tube current outside the pulsing window decreased to 20% or 4% of the nominal tube current and thus, significantly reducing the radiation dose up to 40% (20).We aimed to evaluate the visibility of coronary arteries and bypass-grafts in patients who underwent DSCT angiography without HR control and to determine optimal intervals for image reconstruction.     

Clinical effect of double coaxial self-expandable metallic stent in management of malignant colon obstruction

PURPOSE

We aimed to evaluate the clinical effectiveness and safety of double coaxial self-expandable metallic stent (DCSEMS) in management of malignant colonic obstruction as a bridge to surgery or palliation for inoperable patients.

METHODS

Between April 2006 and December 2012, 49 patients (27 males and 22 females; median age, 68 years; age range, 38–91 years) were selected to receive decompressive therapy for malignant colonic obstruction by implanting a DCSEMS. Application of DCSEMS was attempted in 49 patients under fluoroscopic guidance. The obstruction was located in the transverse colon (n=2), descending colon (n=7), sigmoid colon (n=24), rectosigmoid junction (n=6), and the rectum (n=10). The intended use of DCSEMS was as a bridge to elective surgery in 23 patients and palliation in 26 patients.

RESULTS

Clinical success, defined as >50% dilatation of the stent with subsequent symptomatic improvement, was achieved in 48 of 49 patients (98%). The stent was properly inserted in all patients. No immediate major procedure-related complications occurred. One patient in the bridge-to-surgery group had colon perforation three days after DCSEMS application. Four patients had late migrations of the double stent.

CONCLUSION

Application of DCSEMS is safe and effective in management of malignant colonic obstruction; it prevents stent migration and tumor ingrowth and lowers perforation rate during the stent application.Fluoroscopic or endoscopic placement of either bare or covered expandable metallic stents was shown to be a safe, easy, and effective technique as a bridge to surgery and palliative treatment of colorectal cancer (1, 2). However, tumor ingrowth and stent migration have been reported as weaknesses in conventional single bare and covered stents, respectively (2–4). The use of bare stents has been hindered by progressive tumor ingrowth through the wire filaments of the bare stents and food residue or hard fecal impaction proximal to or at the level of the stent insertion site (5, 6). In contrast, the use of covered expandable metallic stents has been associated with stent migration (5, 7). To overcome the limitations associated with conventional bare and covered stents, a double coaxial self-expandable metallic stent (DCSEMS) has been developed to combine the strengths of bare and covered stents (7, 8).The purpose of the present study was to report our experiences with fluoroscopic-guided placement of double stents in management of malignant colorectal obstruction as a bridge to surgery or palliative treatment.     

Development,growth, propagation,and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and “how to” guide

The VX2 tumor is a leporine anaplastic squamous cell carcinoma characterized by rapid growth, hypervascularity, and facile propagation in the skeletal muscle. Since its introduction over 70 years ago, it has been used to model a variety of malignancies, and is commonly employed by interventional radiologists in preclinical investigations of hepatocellular carcinoma. However, despite the widespread and lasting popularity of the model, there are few technical resources detailing its use. Herein, we present a comprehensive pictorial outline of the technical methodology for development, growth, propagation, and angiographic utilization of the rabbit VX2 liver tumor model.The rabbit VX2 tumor model has played a longstanding role in experimental oncology. Developed in 1930–1940 by Rous et al. (1, 2), the VX2 tumor is a virus-induced anaplastic squamous cell carcinoma characterized by hypervascularity, rapid growth, and easy propagation in the skeletal muscle (3, 4). Since its introduction, the tumor has been used to model cancers of the head and neck (5), kidney (6), brain (7), lung (8), urinary bladder (9), uterus (10), liver (11, 12), bone (13), and pancreas (14). The high growth rate and the relatively large size of rabbit vasculature render the model particularly well suited for use by interventional radiologists, and in recent years the model has been employed in numerous studies pertaining to the imaging and locoregional treatment of hepatocellular carcinoma (15–19). However, despite the widespread and lasting popularity of the model, there are few, if any, comprehensive technical resources detailing its use, leaving many key procedural details to be conveyed anecdotally. Lack of a technical guide may also represent a barrier to entry of interventional radiologists into translational research. With that in mind, this review is intended to provide a complete pictorial overview of the development, growth, propagation, and angiographic utilization of the rabbit VX2 tumor model based on the experience of a single operator in order to serve as a reference for novice and experienced investigators alike.     

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience

PURPOSE

We aimed to describe the frequency of adverse events after computed tomography (CT) fluoroscopy-guided irreversible electroporation (IRE) of malignant hepatic tumors and their risk factors.

METHODS

We retrospectively analyzed 85 IRE ablation procedures of 114 malignant liver tumors (52 primary and 62 secondary) not suitable for resection or thermal ablation in 56 patients (42 men and 14 women; median age, 61 years) with regard to mortality and treatment-related complications. Complications were evaluated according to the standardized grading system of the Society of Interventional Radiology. Factors influencing the occurrence of major and minor complications were investigated.

RESULTS

No IRE-related death occurred. Major complications occurred in 7.1% of IRE procedures (6/85), while minor complications occurred in 18.8% (16/85). The most frequent major complication was postablative abscess (4.7%, 4/85) which affected patients with bilioenteric anastomosis significantly more often than patients without this condition (43% vs. 1.3%, P = 0.010). Bilioenteric anastomosis was additionally identified as a risk factor for major complications in general (P = 0.002). Minor complications mainly consisted of hemorrhage and portal vein branch thrombosis.

CONCLUSION

The current study suggests that CT fluoroscopy-guided IRE ablation of malignant liver tumors may be a relatively low-risk procedure. However, patients with bilioenteric anastomosis seem to have an increased risk of postablative abscess formation.About 70% of hepatic metastases are nonresectable because of their anatomic location, the presence of comorbidities, or limited hepatic functional reserve (1). In these patients and in case of nonresectable primary liver tumors, percutaneous thermal ablation procedures, such as radiofrequency (RF) and microwave ablation, have become effective tools for treating hepatic malignancies (2–4). However, the effectiveness of RF and microwave treatment may be limited, either because of thermal damage to temperature-sensitive structures located in close proximity to the target tissue (5) or because of incomplete ablation of tumors adjacent to major hepatic vessels due to a phenomenon commonly termed “heat-sink effect” (6–10) which describes the loss of the applied thermal energy through the blood flow in those major vessels, whereby the effective energy application remains inadequate to ablate the target lesion.Irreversible electroporation (IRE) is a theoretically nonthermal ablation technique that delivers a series of high-voltage millisecond electrical pulses to the surrounding tissue, thus leading to irreversible disruption of the integrity of cell membranes and subsequent cell death by apoptosis (11–14). IRE may overcome the problems raised with thermal ablation: previous animal studies reported that bile ducts, blood vessels, nerves, and connective tissues are affected by IRE; however, regeneration is possible to some extent due to preservation of the tissue architecture (12, 13, 15–19). Moreover the feasibility of inducing cell death up to a vessel wall without any perivascular sparing was shown with IRE (12, 13, 18). The safety of IRE in the treatment of humans has been described (20). First reports have described potential complications after IRE, such as hemorrhage requiring blood transfusion (1.2%, two of 167 ablation procedures), portal vein thrombosis (3.2%, one of 31 ablation procedures), injury to bile ducts (1.8%, three of 167 ablation procedures), and infection (3.6%, six of 167 ablation procedures) (21, 22). However, few data are available for evaluating the potential risk factors associated with the occurrence of post-IRE complications.The purpose of this study was to review the frequency of mortality and morbidity after computed tomography (CT) fluoroscopy-guided liver IRE conducted at a single center and assess the factors influencing the occurrence of major complications.     

MRI features of breast lymphoma: preliminary experience in seven cases

PURPOSE

We aimed to evaluate the imaging features of breast lymphoma using magnetic resonance imaging (MRI).

METHODS

This retrospective study consisted of seven patients with pathologically confirmed breast lymphoma. The breast lymphomas were primary in six patients and secondary in one patient. All patients underwent preoperative dynamic contrast-enhanced MRI and one underwent additional diffusion-weighted imaging (DWI) with a b value of 600 s/mm². Morphologic characteristics, enhancement features, and apparent diffusion coefficient (ADC) values were reviewed.

RESULTS

On MRI, three patients presented with a single mass, one with two masses, two with multiple masses, and one with a single mass and a contralateral focal enhancement. The MRI features of the eight biopsied masses in seven patients were analyzed. On MRI, the margins were irregular in six masses (75%) and spiculated in two (25%). Seven masses (87.5%) displayed homogeneous internal enhancement, while one (12.5%) showed rim enhancement. Seven masses (87.5%) showed a washout pattern and one (12.5%) showed a plateau pattern. The penetrating vessel sign was found in two masses (25%). One patient with two masses underwent DWI. Both masses showed hyperintense signal on DWI with ADC values of 0.867×10⁻³ mm²/s and 0.732×10⁻³ mm²/s, respectively.

CONCLUSION

Breast lymphoma commonly presents as a homogeneously enhancing mass with irregular margins and displays a washout curve pattern on dynamic MRI. A low ADC value may also indicate a possible diagnosis of breast lymphoma.Breast lymphoma, which constitutes only 0.04%–0.5% of all breast malignancies (1), can be divided into primary or secondary breast lymphoma (2). The majority of breast lymphomas are diffuse large B-cell lymphoma (3). The spontaneous regression of a breast lymphoma is rare and the five-year overall survival rate is 53% (1, 4). Early-stage identification and the use of radiotherapy are favorable prognostic factors, while mastectomy is associated with a poorer survival (1, 5). Therefore, a preoperative diagnosis of breast lymphoma would mean an earlier diagnosis and likely avoid unnecessary aggressive procedures.Previous studies demonstrated mammographic and ultrasonographic findings of breast lymphoma (6–8). Most lesions were high-density masses without spiculated margins and calcifications on mammography and noncircumscribed hypoechoic masses on ultrasonography (6–8). However, none were pathognomonic.Data on the magnetic resonance imaging (MRI) of breast lymphoma are limited to some single case reports (4, 7, 9–19) and small sample size case series (8, 20–23). The morphology and time-signal intensity curve (TIC) of breast lymphoma on MRI are variable. Diffusion-weighted imaging (DWI) is a functional imaging technique that is useful for distinguishing lymphoma from other malignant tumors in other systems (24, 25). However, to the best of our knowledge, the value of DWI in differentiating breast lymphoma from other malignant breast lesions has not been discussed. Therefore, the purpose of this study is to assess the MRI and DWI features of breast lymphoma.     

Vacuum-assisted stereotactic biopsy for isolated BI-RADS 4 microcalcifications: evaluation with histopathology and midterm follow-up results

PURPOSE

The aim of this study was to evaluate the 10-gauge vacuum-assisted stereotactic biopsy (VASB) of isolated Breast Imaging Reporting and Data System (BI-RADS) 4 microcalcifications, using histology and follow-up results.

METHODS

From January 2011 to June 2013, VASB was performed on 132 lesions, and 66 microcalcification-only lesions of BI-RADS 4 were included into our study. VASB was performed using lateral decubitis stereotaxy for all patients. Pathologic results of VASB and further surgical biopsies were reviewed retrospectively. Patients who were diagnosed to have benign lesions by VASB were referred for follow-up. VASB and surgical histopathology results were compared to determine the underestimation ratios.

RESULTS

Fifteen out of 66 lesions from 63 patients (median age, 47 years; range, 34–88 years) were identified as malignant by VASB. Pathological results after surgery revealed three cases of invasive ductal carcinoma among the 12 VASB-diagnosed ductal carcinoma in situ (DCIS) lesions, for a DCIS underestimation rate of 25%. The atypical ductal hyperplasia underestimation rate was 0% for the three lesions. The follow-up period was at least 10 months, with an average of 22.7 months for all patients and 21.2 months for patients with VASB-diagnosed benign lesions. None of the patients had malignancy during the follow-ups. The false-negative rate was 0% in the follow-up of 48 patients.

CONCLUSION

VASB should be the standard method of choice for BI-RADS 4 microcalcifications. This method obviates the need for a surgical procedure in 73% of BI-RADS 4 microcalcification-only patients.Recently, growing concern regarding breast cancer has resulted in increasingly frequent recommendations for screening mammography and more intensive requirements for biopsies of subclinical (impalpable) lesions. Microcalcifications may be the only finding of early stage malignancies, including atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). Isolated microcalcifications comprise 55% of the suspicious lesions detected by mammography (1, 2).Until recently, the most common approach for this type of pathology has been surgical excision of the lesion after wire localization by mammographic guidance. However, studies have shown that surgical excisions result in benign histology in 76%–81% of the cases (3, 4). Understandably, surgical excisions generate anxiety in most patients. Additionally, the cost and morbidity associated with the surgical procedures have prompted many physicians to explore less invasive, alternative procedures (5–7).For the past two decades, vacuum-assisted stereotactic biopsy (VASB) has been increasingly used for histologic diagnosis of suspicious microcalcifications. The 11-gauge VASB allows radiologists to obtain a sufficiently large specimen with better calcification retrieval (8), a lower re-biopsy rate, and fewer histologic underestimates (9–11), compared with other core-needle biopsy techniques. The false-negative rate of VASB procedure can be as low as 0.6% when performed by experienced radiologists (12). This technique also has some cost advantages compared to needle-localized surgical biopsy (NLSB)(13).Although numerous studies of VASB under real-time ultrasonography (US) or mammography guidance exist, none have included a sufficient subgroup analysis (2, 14). Core needle biopsy is the cheapest and easiest technique for lesions that can be visualized by US; however, isolated, suspicious microcalcifications can only be sampled by means of stereotaxy. To our knowledge, there is no study that has specifically evaluated isolated Breast Imaging Reporting and Data System (BI-RADS) 4 microcalcifications, even though these constitute the majority of subclinical lesions detected by screening mammography. BI-RADS 3 microcalcifications can be followed confidently, whereas BI-RADS 5 microcalcifications should be subjected to surgical excision in all cases.BI-RADS 4 microcalcifications are the most critical issue facing radiologists reporting screening mammography. Through the routine use of VASB for BI-RADS 4 microcalcifications, surgical excision can be avoided in most patients (3, 4). It is important to consider the underestimation and false-negative rates, specifically for isolated BI-RADS 4 microcalcifications, before considering more invasive methods (surgical biopsies) as a further step after VASB. The aim of this study was to evaluate the utility of VASB for isolated BI-RADS 4 microcalcifications by studying their midterm follow-up results.     

Silent cerebral emboli following percutaneous closure of atrial septal defect in pediatric patients: a diffusion-weighted MRI study

PURPOSE

The aim of this prospective study was to investigate the incidence of silent cerebrovascular embolic events associated with percutaneous closure of atrial septal defect (ASD) in pediatric patients.

METHODS

A total of 23 consecutive pediatric patients (mean age, 10.4±3.8 years; range, 4–17 years) admitted for transcatheter closure of ASD were recruited in the study. The patients were scanned with a 1.5 Tesla clinical scanner. Two cranial magnetic resonance imaging (MRI) examinations were acquired before the procedure and within 24 hours following the catheterization. MRI included turbo spin-echo fluid-attenuated inversion recovery (FLAIR) sequence and diffusion-weighted imaging technique with single-shot echo-planar spin-echo sequence. The transcatheter closure of ASD was performed by three expert interventional cardiologists. Amplatzer septal occluder device was implemented for the closure of the defect. No contrast medium was administered in the course of the procedure.

RESULTS

None of the patients had diffusion restricted cerebral lesions resembling microembolic infarctions on postprocedural MRI. Preprocedural MRI of two patients revealed nonspecific hyperintense white matter lesions on FLAIR images with increased diffusion, which were considered to be older ischemic lesions associated with previously occurred paradoxical embolism.

CONCLUSION

The current study suggests that percutaneous closure of the ASD, when performed by experienced hands, may be free of cerebral microembolization in pediatric patients. However, due to the relatively small sample size, further studies with larger patient groups are needed for the validation of our preliminary results.Acute symptomatic cerebral infarction associated with percutaneous cardiovascular intervention has been reported to have an incidence of 0.09%–1.0% when evaluated solely with neurologic examination (1–4). However, asymptomatic cerebral microemboli detected with transcranial Doppler ultrasonography (US) monitoring and diffusion-weighted imaging (DWI) following either conventional or interventional cardiac catheterization is unexpectedly more common (4–10). The incidence revealed with DWI studies varies between 3.3% and 77% depending on risk factors associated with the patient population and the procedure, in adult studies (9, 10).Due to technologic developments, more children with congenital heart disease are taken to the cardiac catheterization laboratory for interventional treatment. The subclinical focal neurologic events are more difficult to reveal solely with neurologic examination in children compared with the adult age group. Therefore, it is crucial to determine the silent neurologic complications and the risk factors associated with heart catheterization in the pediatric population. There have been a few studies in adults (10–12), but to the best of our knowledge, no clinical studies revealed the association of subclinical ischemic lesions with transcatheter closure of atrial septal defect (ASD) in pediatric patients.Transcatheter closure of ASD, which is an alternative to open heart surgery, is applied as a first-line treatment modality in appropriate patients (13). Despite increasing rates of complete closure with ongoing technologic innovations, neurologic complications associated with peri-interventional cerebral embolism have been reported (10, 11). In this single-center, prospective study, we aimed to investigate the incidence and the risk factors of silent cerebral embolism following transcatheter closure of ASD with the Amplatzer septal occluder (AGA Medical Corp.) device in pediatric patients.     

Paratracheal air cysts: prevalence and relevance to pulmonary emphysema and bronchiectasis using thoracic multidetector CT

PURPOSE

We aimed to determine the prevalence of paratracheal air cysts (PTACs) and the relationship of PTACs with emphysema and bronchiectasis through retrospective analysis of multidetector computed tomography (MDCT) findings.

METHODS

MDCT findings of 1027 consecutive patients who underwent routine thorax examination between January 2012 and January 2013 were evaluated retrospectively for the presence of PTACs. Localization of the PTACs, as well as their size, shape, and relationship with the trachea were examined. Presence of emphysema and bronchiectasis was recorded, and bronchiectasis severity index was calculated when present. We randomly selected 80 patients who had no visible PTACs as the control group. The findings of patients with and without PTACs were compared.

RESULTS

PTACs were determined in 82 of 1027 patients (8%), in 8.8% of females and 7.3% of males. The presence of PTACs was determined to be independent of gender (P = 0.361). Eighty-one PTACs (98.8%) were located in the right side of the trachea and 56.1% had a tracheal connection. The presence of PTACs significantly correlated with the presence and severity of bronchiectasis (P = 0.001 and P = 0.005 respectively). There was no significant relationship between the presence of PTACs and the presence of emphysema on CT images (P = 0.125).

CONCLUSION

The prevalence of PTACs was determined as 8% in this study. There was significant association between PTACs and bronchiectasis.Paratracheal air cysts (PTACs) are small collections of air adjacent to the trachea at the level of the thoracic inlet (1). Pathological diagnosis of PTACs in surgically confirmed cases includes tracheal diverticulum, lymphoepithelial cyst, and bronchogenic cyst (1–3). These cysts are covered with ciliary columnar epithelium and connected with the trachea (4). The majority of PTACs are reported as tracheal diverticula in the literature, due to their connection with the trachea (2). The thoracic inlet between the cartilage and muscle layers in right posterolateral wall of the trachea is the most common location for PTACs. A relationship may be seen between an isolated PTAC and the trachea l lumen (5). These lesions may cause recurrent infections by acting as a reservoir for secretions.Occasionally, PTACs can be confused with other causes of extraluminal air collections as laryngocele, pharyngocele, Zenker’s diverticulum, apical hernia of the lung, mediastinal air, apical paraseptal blebs, or bullae. To distinguish PTACs from other pathologies, its typical location in the right posterior paratracheal region at the thoracic inlet can be helpful: PTACs locate away from the lung pleura, communicate with the trachea and have rounded margins that can be differentiated from emphysematous changes (6).PTACs are usually discovered incidentally on thorax computed tomography (CT). They may be associated with a chronic cough or chronic obstructive pulmonary diseases (COPD). The reported prevalence of PTACs ranges from 0.75% to 8.1% (4, 6–8). There have been a limited number of studies reporting the incidence of PTACs related to COPD or emphysema as detected by CT, and the reported results are variable (4, 6, 8–11). The relationship between PTACs and pulmonary emphysema or bronchiectasis is still unclear. To our knowledge, no published study has evaluated the relationship between PTACs and bronchiectasis, using a bronchiectasis severity index and objective measures to determine the extent of bronchiectasis on CT images.The purpose of our study was to evaluate the prevalence and characteristics of PTACs, as well as their relationship with bronchiectasis and emphysema, on thorax CT scans.     

Traumatic diaphragmatic injury: a review of CT signs and the difference between blunt and penetrating injury

PURPOSE

We aimed to present the frequency of computed tomography (CT) signs of diaphragmatic rupture and the differences between blunt and penetrating trauma.

MATERIALS AND METHODS

The CT scans of 23 patients with surgically proven diaphragmatic tears (both blunt and penetrating) were retrospectively reviewed for previously described CT signs of diaphragmatic injuries. The overall frequency of CT signs was reported; frequency of signs in right- and left-sided injuries and blunt and penetrating trauma were separately tabulated and statistically compared.

RESULTS

The discontinuous diaphragm sign was the most common sign, observed in 95.7% of patients, followed by diaphragmatic thickening (69.6%). While the dependent viscera sign and collar sign were exclusively observed in blunt-trauma patients, organ herniation (P = 0.05) and dangling diaphragm (P = 0.0086) signs were observed significantly more often in blunt trauma than in penetrating trauma. Contiguous injury on either side of the diaphragm was observed more often in penetrating trauma (83.3%) than in blunt trauma (17.7%).

CONCLUSION

Knowledge of the mechanism of injury and familiarity with all CT signs of diaphragmatic injury are necessary to avoid a missed diagnosis because there is variability in the overall occurrence of these signs, with significant differences between blunt and penetrating trauma.Traumatic diaphragmatic injury has been found in 3%–8% of patients undergoing surgical exploration after blunt trauma and in 10% of patients with penetrating trauma (1, 2). The rate of initially missed diagnoses on computed tomography (CT) ranges from 12% to 63%. A missed diagnosis can later present as intrathoracic visceral herniation and strangulation with a mortality rate of 30%–60% (2, 3). In this era of increasing nonoperative management for most cases of blunt abdominal trauma, it becomes essential to diagnose diaphragmatic rupture on imaging to ensure early and timely operative repair of the rupture. The reasons for missed early diagnoses include potentially distracting and more severe thoracic and abdominal visceral injuries and lack of familiarity with all the imaging appearances and signs of diaphragmatic rupture (2, 4).Various imaging modalities including chest radiographs, ultrasonography, CT, and magnetic resonance imaging have been used in the diagnosis of diaphragmatic rupture (1). Currently, multidetector CT (MDCT) is the modality of choice for the detection of diaphragmatic injury. MDCT has increased the accuracy of diagnosis of diaphragmatic rupture. MDCT has inherent technical advantages, such as rapid, volumetric data acquisition for the chest and abdomen within a single breath hold, minimization of motion artifacts, thin-section reconstruction and sagittal and coronal reformat-reducing partial-volume effects that assist in diagnosing subtle defects (1). MDCT also aids in detecting the associated chest, abdomen, ribs, and bony injuries in these polytrauma patients. Various studies have revealed CT to have a variable sensitivity and specificity of 61%–87% and 72%–100%, respectively, for the diagnosis of diaphragmatic rupture (1, 5–7). Killeen et al. (6) demonstrated that the sensitivity for detecting left-sided ruptures (78%) is higher than for right-sided ruptures (50%). This finding has been attributed to the better soft tissue-fat contrast on the left side and the difficulty in diagnosing subtle liver herniation on the right side.Various signs of diaphragmatic rupture have been described on CT. These signs have been divided into direct and indirect signs and signs of uncertain/controversial origin, according to Desir and Ghaye (8), and have been tabulated in 2, 3).

Table 1.

CT signs of diaphragmatic injury^a

The potential role of modern US in the follow-up of patients with retroperitoneal fibrosis

PURPOSE

We aimed to evaluate a standardized ultrasonography (US) algorithm for the visualization of pathologic para-aortic tissue in retroperitoneal fibrosis (RPF).

MATERIALS AND METHODS

Thirty-five patients with lumbar RPF of typical extent, as determined by abdominal magnetic resonance imaging, were included. Examinations were conducted using standardized abdominal US with axial sections obtained at the levels of the renal arteries, aortic bifurcation, and both common iliac arteries. Imaging of each section was acquired with fundamental B-mode (US) and tissue harmonic imaging, respectively. In addition, we examined RPF visualized using extended field-of-view US.

RESULTS

Tissue harmonic imaging adequately visualized RPF of typical extent in 33 patients (94.2%). Excellent and good visualization with mild artifacts were achieved in 25 (71.4%) and six (17.1%) patients, respectively. When RPF spread along the iliac arteries, excellent visualization was achieved in 38.7% for the left side and 34.5% for the right side. There were significantly fewer diagnostic examinations for the right iliac (27.6%) than for the left one (9.7%) (P = 0.016). Overall, harmonic imaging achieved significantly better visualization than fundamental B-Mode (P < 0.001).

CONCLUSION

We described the first systematic evaluation of RPF visualization by modern US techniques. The best imaging quality was found in the typical RPF location, at the level of the aortic bifurcation. These results advocate for the presented US algorithm as an efficient follow-up alternative to cross-sectional imaging in RPF patients.Chronic periaortitis or retroperitoneal fibrosis (RPF) is a rare fibrosing disease that affects para-aortic tissues (1–3). It typically presents as a proliferating lumbar process surrounding the ureters and retroperitoneal vascular structures (Fig. 1) (2, 4). Sporadic, atypical manifestations in pelvic and mesenteric regions are also possible (5).Open in a separate windowFigure 1. a–c.Typical extent of the retroperitoneal fibrosis surrounding the infrarenal aorta (a). Spreading of the fibrosis to the renal arteries and along the common iliac arteries (b). Standardized US examination with four transverse sections (c). AO, aorta; AIC, common iliac artery; RA, renal artery; RPF, retroperitoneal fibrosis.Magnetic resonance imaging (MRI) allows precise evaluation of the extent and complications (6). RPF presents as hypointense (often isointense to striated muscle) plaques in native T1-weighted magnetic resonance (MR) images with significant gadolinium contrast enhancement of active and untreated retroperitoneal fibrosis (7–9).Ultrasonography (US) is primarily used in patients with RPF for a rapid and practical diagnosis of consecutive hydronephrosis (6). RPF presents as a smooth-bordered mass with either an echo-poor or echo-free signal (10, 11). Two studies in the 1980s indicated that US revealed only a poor overall sensitivity in the detection of RPF (12, 13). Feinstein et al. (14) reported that only 25% of affected patients with computed tomography (CT)-mediated diagnosis of RPF showed corresponding ultrasonographic abnormalities. Since that time the quality of US scanners has improved dramatically, and modern techniques, such as tissue harmonic imaging (THI) and extended field-of-view US, have significant advantages for routine clinical diagnosis (15–17). Today, US has established itself as an effective and cost-efficient imaging method for the screening and follow-up of infrarenal aortic aneurysms (18, 19). US, however, is not used routinely for RPF follow-up, nor has a systematic evaluation of modern ultrasonographic methods been available to date.The aim of the present study was to evaluate the potential role of modern ultrasonographic techniques for the visualization of fibrous tissue in patients with prediagnosed RPF.     

Diffusion-weighted MRI findings of treated and untreated retroperitoneal fibrosis

PURPOSE

We aimed to evaluate diffusion-weighted imaging (DWI) findings in patients with treated and untreated retroperitoneal fibrosis (RPF).

METHODS

We analyzed magnetic resonance imaging examinations of 44 RPF patients (36 male, 8 female), of which 15 were untreated and 29 were under therapy. Qualitative DWI and T1 postcontrast signal intensities and the largest perivascular extent of RPF were compared between treated and untreated groups and correlated to erythrocyte sedimentation rate and C-reactive protein values. Quantitative DWI signal intensities and apparent-diffusion-coefficients were calculated in regions-of-interest, together with a relative index between signal intensities of RPF and psoas muscle in 15 untreated patients and 14 patients under treatment with remaining perivascular fibrosis of more than 5 mm.

RESULTS

The extent of RPF in untreated patients was significantly larger compared with the extent of RPF in treated patients (P < 0.0001). DWI signal intensities were significantly higher in untreated patients than in patients under therapy (mean, 27 s/mm² vs. 20 s/mm²; P = 0.009). The calculated DWI-index was significantly higher in untreated patients than in patients under therapy (P = 0.003).

CONCLUSION

Our data show significant differences in the DWI findings (b800 signal intensities and relative DWI-index) of patients with treated and untreated RPF. DWI is a promising technique in the assessment of disease activity and the selection of patients suitable for medical therapy.Retroperitoneal fibrosis (RPF) is a rare disease affecting the retroperitoneal space (1–3). It presents as retroperitoneal proliferation of fibrous tissue surrounding the retroperitoneal vascular structures and abutting the medial aspect of the ureters. Clinical findings of RPF are non-specific; the most common symptom is chronic back pain. Further symptoms include lower extremity edema, deep vein thrombosis, oliguria, and urinary tract infection (3). Computed tomography (CT) and magnetic resonance imaging (MRI) are the preferred imaging modalities for the diagnosis of RPF (3). Retroperitoneal fibrosis shows contrast enhancement of gadolinium containing contrast media in MRI (4). Medical treatment is classically based on steroids like prednisone (3). Recent studies suggested tamoxifen as another safe and effective treatment alternative (5).The assessment of disease activity is relevant for planning of further medical or surgical therapy (6, 7). Nowadays the disease activity is assessable by positron emission tomography tracer uptake (3), with a relatively low resolution and the need of ionized radiation. As an alternative, dynamic contrast-enhanced MRI was suggested for the evaluation of disease activity (7, 8). However, gadolinium may be contraindicated in patients with impaired renal function due to the potential development of nephrogenic systemic fibrosis (NSF) (9). This is especially relevant in RPF patients with postrenal failure due to ureteral compression. For those cases a supplemental method for the determination of disease activity would be helpful.Diffusion-weighted imaging (DWI) is a radiation-free unenhanced MRI modality that has been applied for the detection of bowel inflammation in patients with chronic inflammatory bowel diseases (10, 11), as well as for oncological retroperitoneal and abdominal applications (12–14). Therefore, we aimed to evaluate the application and findings of DWI in patients with treated and untreated RPF disease.     

Contrast medium administration and image acquisition parameters in renal CT angiography: what radiologists need to know

Over the last decade, exponential advances in computed tomography (CT) technology have resulted in improved spatial and temporal resolution. Faster image acquisition enabled renal CT angiography to become a viable and effective noninvasive alternative in diagnosing renal vascular pathologies. However, with these advances, new challenges in contrast media administration have emerged. Poor synchronization between scanner and contrast media administration have reduced the consistency in image quality with poor spatial and contrast resolution. Comprehensive understanding of contrast media dynamics is essential in the design and implementation of contrast administration and image acquisition protocols. This review includes an overview of the parameters affecting renal artery opacification and current protocol strategies to achieve optimal image quality during renal CT angiography with iodinated contrast media, with current safety issues highlighted.Personalized medicine is a popular topic in radiology today. Scientists are flooding academic journals, conference proceedings, and book chapters with arguments about radiation reduction strategies with a personalized approach. However, contrast media (CM) dose reduction has been overlooked, which is of great concern. As such, 3% of all patients admitted for renal dialysis are a direct result of excessive CM volume delivered during radiologic imaging in the course of their hospital stay (1).Studies suggest that CM volumes employed during renal computed tomography (CT) angiography (CTA) range from 30–120 mL (2–4). This wide array of CM dose has different effects on scanner parameters. For example, employing 30 mL CM volume with a tube current selection of 80 kVp renders acceptable image quality. However, image quality can either be quantitative or qualitative in nature, which increase the subjectivity of good versus acceptable image quality with desired CM doses. Therefore, judging optimal image quality is determined by the amount of noise and vascular opacification of the renal arteries.Vascular opacification that is too low may compromise the visualization of small renal vasculature and underestimate plaque formation and stenosis (5). Previous studies on contrast-injection protocols for renal CTA suggested that the adequate attenuation value for the arteries is greater than 211 Hounsfield units (HU) (6). However, attenuation values of the renal arteries have reached as high as 435±48 HU, while those of the renal veins have reached 277±29 HU (7).The sensitivity and specificity for diagnosing greater than 50% renal artery stenosis during renal CTA range from 67%–100% and 77%–98%, respectively (8). Renal magnetic resonance angiography (MRA) has sensitivity and specificity of 88%–100% and 70%–100% with low interobserver variability, especially for severe stenosis greater than 70% (9).Renal CTA provides accurate, noninvasive, and time-efficient diagnostic evaluation for medical management of renal arterial disease as well as creating a roadmap prior to surgical intervention. Such clinical questions arise when a hypertensive individual has renal CTA to exclude renal artery stenosis, fibromuscular dysplasia, or dissection. Pathology-specific renal CTA examinations include determining if vasculitis involves the renal arteries or the extent of renal aneurysmal changes. Preoperative renal CTA planning can be useful for nephron-sparing surgery prior to resection of renal masses or as post-procedural follow-up of renal stenting or surgical revascularization. Finally, renal CTA is also employed in the evaluation of the kidney donor and recipient prior to transplantation.Large volumes of CM greater than 100 mL could potentially lead to contrast-induced nephropathy (CIN). CIN is the third leading cause of hospital-acquired acute renal failure, accounting for 11% of all cases, contributing to a prolonged hospital stay and increased medical costs (10). It has raised awareness of the need to optimize CM administration. There is a significant correlation between increased CM volume administration and the risk of CIN, i.e., higher doses of CM increase the risk of CIN (11–13). Additionally, CM doses less than 30 mL can be safely given in patients with chronic renal failure (14).     

Efficacy of CT in diagnosis of transudates and exudates in patients with pleural effusion

PURPOSE

We aimed to evaluate the efficacy of multidetector computed tomography (CT) imaging in diagnosis of pleural exudates and transudates using attenuation values.

MATERIALS AND METHODS

This retrospective study included 106 patients who were diagnosed with pleural effusion between January 2010 and June 2012. After the patients underwent chest CT, thoracentesis was performed in the first week. The attenuation values of the pleural effusions were measured in all patients.

RESULTS

According to Light’s criteria, 30 of 106 patients with pleural effusions had transudates, and the remaining patients had exudates. The Hounsfield unit (HU) value of the exudates (median, 12.5; range, 4–33) was significantly higher than that of the transudates (median, 5; range, 2–15) (P = 0.001). Additionally, when evaluated by disease subgroups, congestive heart failure and empyema were predictable in terms of median HU values of the pleural effusions with high and moderate sensitivity and specificity values (84.6% and 81.2%, respectively; 76.9% and 66.7%, respectively). Compared with other patients, the empyema patients had significantly more loculation and pleural thickening.

CONCLUSION

CT attenuation values may be useful in differentiating exu-dates from transudates. Although there is an overlap in most effusions, exudate can be considered when the CT attenuation values are >15 HU. Because of overlapping HU values, close correlation with clinical findings is essential. Additional signs, such as fluid loculation and pleural thickness, should be considered and may provide further information for the differentiation.Pleural effusion is a common clinical problem; indeed, it can arise from many diseases (1, 2). The first step in assessing a pleural effusion is to decide whether the pleural fluid is a transudate or an exudate (3). Transudate is caused by imbalances in hydrostatic and oncotic forces. It results from diseases such as heart failure, kidney failure, and cirrhosis. However, an exudate occurs when local factors influencing the accumulation of pleural fluid are altered. Exudates can be caused by clinical conditions such as pneumonia, malignancy, and thromboembolism (4).Although clinical and radiological findings may provide significant evidence about the cause(s) of pleural effusion(s), it may still be necessary to evaluate some cases with diagnostic thoracentesis (4, 5). Clinically, exudative effusion can be successfully separated from transudative effusion using Light’s criteria. The nature of the pleural effusion is based on diagnostic thoracentesis (1, 2). However, computed tomography (CT) can be used to evaluate the nature of pleural effusions to avoid the complications of thoracentesis (6, 7). Features such as pleural nodules, pleural thickening, loculation, extrapleural fat tissue thickness, and effusion density can be evaluated by CT to discriminate between exudates and transudates (8). Only two reported studies have examined CT attenuation values in patients with pleural effusions (9, 10); these showed different attenuation values for evaluation of pleural effusions.The aim of the present study was to evaluate the efficacy of multidetector CT (MDCT) images in diagnosing pleural exudates and transudates using attenuation values.     

Reliability of semiquantitative assessment of osteophytes and subchondral cysts on tomosynthesis images by radiologists with different levels of expertise

PURPOSE

We aimed to assess reliability of the evaluation of osteophytes and subchondral cysts on tomosynthesis images when read by radiologists with different levels of expertise.

MATERIALS AND METHODS

Forty subjects aged >40 years had both knees evaluated using tomosynthesis. Images were read by an “experienced” reader (musculoskeletal radiologist with prior experience) and an “inexperienced” reader (radiology resident with no prior experience). Readers graded osteophytes from 0 to 3 and noted the presence/absence of subchondral cysts in four locations of the tibiofemoral joint. Twenty knees were randomly selected and re-read. Inter- and intrareader reliabilities were calculated using overall exact percent agreement and weighted κ statistics. Diagnostic performance of the two readers was compared against magnetic resonance imaging readings by an expert reader (professor of musculoskeletal radiology).

RESULTS

The experienced reader showed substantial intrareader reliability for graded reading of osteophytes (90%, κ=0.93), osteophyte detection (95%, κ=0.86) and cyst detection (95%, κ=0.83). The inexperienced reader showed perfect intrareader reliability for cyst detection (100%, κ=1.00) but intrareader reliability for graded reading (75%, κ=0.79) and detection (80%, κ=0.61) of osteophytes was lower than the experienced reader. Inter-reader reliability was 61% (κ=0.72) for graded osteophyte reading, 91% (κ=0.82) for osteophyte detection, and 88% (κ=0.66) for cyst detection. Diagnostic performance of the experienced reader was higher than the inexperienced reader regarding osteophyte detection (sensitivity range 0.74–0.95 vs. 0.54–0.75 for all locations) but diagnostic performance was similar for subchondral cysts.

CONCLUSION

Tomosynthesis offers excellent intrareader reliability regardless of the reader experience, but experience is important for detection of osteophytes.Tomosynthesis is a digital X-ray imaging technique that allows acquisition of tomographic information (1). In the literature, its use has been reported for imaging of lungs (1–4), breast (5–7), and head and neck region (8–10); for visualization of kidneys through intravenous pyelogram (11); for localization of an endorectal balloon for prostate image-guided radiation therapy (12); and for evaluation of aortic arch calcification (13), and bone and joint pathologies (14–21). While its clinical use has become common in chest and breast imaging, its clinical application in arthritis imaging is scarcely documented in the literature (14, 15, 22).In a recent study, we reported that tomosynthesis had higher sensitivity for detection of osteophytes and subchondral cysts compared to conventional radiography, using magnetic resonance imaging (MRI) findings as the reference standard (15). In that study, the readings were performed by a single expert musculoskeletal radiologist, and the intrareader reliability for this reader was reported as excellent (weighted κ=1.00 for osteophytes and 0.86 for subchondral cysts). Although it is known that reader experience is important for high reliability in radiographic assessment of knee osteoarthritis (23), it is not known whether excellent reliability can be achieved when tomosynthesis images are read by radiologists with different levels of experience.Tomosynthesis is a potentially useful tool in osteoarthritis research and might be used more frequently in the future because of its advantages over radiography. For its use to become more widespread, however, we need to understand whether reader experience affects the reliability of scoring osteoarthritis features on tomosynthesis, as it does with conventional radiography. It is possible that tomosynthesis can provide high reliability even with inexperienced readers because of the tomographic nature of the acquired images.The aim of this study was to determine the intrareader and inter-reader reliability for semiquantitative scoring of osteophytes and subchondral cyst detection using tomosynthesis, when read by radiologists with different levels of experience.     

Effect of imaging parameters on the accuracy of apparent diffusion coefficient and optimization strategies

PURPOSE

We aimed to investigate the effect of key imaging parameters on the accuracy of apparent diffusion coefficient (ADC) maps using a phantom model combined with ADC calculation simulation and propose strategies to improve the accuracy of ADC quantification.

METHODS

Diffusion-weighted imaging (DWI) sequences were acquired on a phantom model using single-shot echo-planar imaging DWI at 1.5 T scanner by varying key imaging parameters including number of averages (NEX), repetition time (TR), echo time (TE), and diffusion preparation pulses. DWI signal simulations were performed for varying TR and TE.

RESULTS

Magnetic resonance diffusion signal and ADC maps were dependent on TR and TE imaging parameters as well as number of diffusion preparation pulses, but not on the NEX. However, the choice of a long TR and short TE could be used to minimize their effects on the resulting DWI sequences and ADC maps.

CONCLUSION

This study shows that TR and TE imaging parameters affect the diffusion images and ADC maps, but their effect can be minimized by utilizing diffusion preparation pulses. Another key imaging parameter, NEX, is less relevant to DWI and ADC quantification as long as DWI signal-to-noise ratio is above a certain level. Based on the phantom results and data simulations, DWI acquisition protocol can be optimized to obtain accurate ADC maps in routine clinical application for whole body imaging.Diffusion-weighted imaging (DWI) measures the degree of water mobility, i.e., random Brownian motion, in vivo and is a noninvasive tool (1–3). DWI has been used mainly in cranial magnetic resonance imaging (MRI) applications to visualize stroke, neoplasms, intracranial infections, traumatic brain injury, and demyelinating processes since early 1990s (4–8). However, in recent years, DWI applications has been extended to breast, musculoskeletal, liver, prostate, pelvis, and general whole body imaging with the development of multichannel coils, parallel imaging, faster gradients, and MRI hardware (9–14). DWI can provide a quantitative map of water diffusion coefficient. Water diffusion coefficient can be calculated from diffusion-weighted images using at least two different DWI values. DWI is achieved by applying diffusion gradients and is called the b-value. Water diffusion coefficient in the tissue is called apparent diffusion coefficient (ADC) and can be calculated from diffusion-weighted images using a linear regression analysis. The term “apparent” is used for diffusion coefficient to differentiate from true diffusion coefficient since the measured water diffusion coefficient in the tissue is influenced by a number of other factors such as capillary network orientation and gross motion in addition to random Brownian motion. ADC measurements are considered to be of greater importance in differential diagnosis of various pathological conditions and its accurate measurement is of great importance (12, 13, 15–18).In the past, the magnetic resonance gradients were much slower and repetition time (TR) and echo-time (TE) were quite long. Thanks to the fast pace of advancement in MRI, the imaging parameters were shortened significantly. Therefore, TR and TE could be reduced in such a way that they could be comparable to tissue relaxation times (T1 and T2) in order to reduce susceptibility artifacts and the total scan time for various DWI applications. As a result of this development, the selection of user controlled imaging parameters, such as TE, number of averages (NEX), number of diffusion preparation pulse, b-value and TR, became much more relevant to DWI and ADC mapping (19–22). However, dependency of ADC maps on some of the user controlled imaging parameters were investigated by few studies in a limited manner (19–25). It is important to mention that even though multi-shot and three-dimensional (3D) DWI sequences are recently proposed to improve diffusion image quality (26–28), single-shot echo-planar imaging (ssEPI) pulse sequence has been the primary sequence in use for DWI in clinical practice for the last two decades.The purpose of this study is to systematically investigate the effects of user controlled diffusion-weighted MRI parameters on ADC values by uniquely combining phantom studies with diffusion signal simulations and to give an insight into optimizing those parameters to obtain more precise ADC maps using the most commonly used ssEPI-based DWI sequence.